Transcatheter aortic valve replacement for native aortic valve regurgitation is feasible but with modest technical success (79.8%).•Balloon-expandable valve use is linked to lower 30-day major adverse cardiac events versus self-expanding valve in high-risk patients.•Long-term outcomes driven by patient risk, not valve type.•Dedicated native aortic regurgitation systems still needed to improve procedural safety.
Transcatheter Aortic Valve Replacement for Severe Native Aortic Valve Regurgitation: A Multicenter and International Registry
Farina, Jacopo;Biscaglia, Simone;
2026
Abstract
Transcatheter aortic valve replacement for native aortic valve regurgitation is feasible but with modest technical success (79.8%).•Balloon-expandable valve use is linked to lower 30-day major adverse cardiac events versus self-expanding valve in high-risk patients.•Long-term outcomes driven by patient risk, not valve type.•Dedicated native aortic regurgitation systems still needed to improve procedural safety.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S2474870625003549-main.pdf
accesso aperto
Descrizione: Full text editoriale
Tipologia:
Full text (versione editoriale)
Licenza:
Creative commons
Dimensione
517.92 kB
Formato
Adobe PDF
|
517.92 kB | Adobe PDF | Visualizza/Apri |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
